ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1565
0,19%
Bitcoin
62.568,44
1,82%
Brent Oil
82,835
0,55%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Arrowhead Pharmaceuticals Inc (ARWR)

  7. Arrowhead Pharmaceuticals Inc (ARWR) Notícias

ARWR

Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ARWR
DataHoraFonteTítuloCódigoCompanhia
09/05/202417:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/05/202419:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
16/04/202410:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/03/202419:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
27/02/202419:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/02/202418:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
17/01/202419:22Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
04/01/202419:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202318:09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
27/06/202317:02Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
09/06/202315:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/05/202320:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
21/03/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
12/02/202313:30ValueWalkHere Are The Five Best- And Worst-Performing Mid-Cap Stocks In Jan. 2023NASDAQ:ARWRArrowhead Pharmaceuticals Inc
11/02/202312:22ValueWalkAshSwap the first stable-swap DEX Launches on MultiversX MainnetNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/02/202318:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/01/202318:47Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
20/01/202311:46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/12/202208:04Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/11/202209:35TipRanksArrowhead Pharmaceuticals (ARWR) Gets a Buy from B.Riley FinancialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/11/202201:15TipRanksRobert W. Baird Remains a Buy on Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202217:25TipRanksArrowhead Pharmaceuticals (ARWR) Receives a Buy from JefferiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202213:25TipRanksMorgan Stanley Remains a Hold on Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202210:50TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR) and Boston Scientific (BSX)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
10/11/202211:05TipRanksB.Riley Financial Sticks to Its Buy Rating for Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
10/11/202209:36TipRanksArrowhead Pharmaceuticals (ARWR) Gets a Hold from SVB SecuritiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
10/11/202201:27TipRanksSVB Securities Sticks to Their Hold Rating for Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/11/202218:58TipRanksArrowhead to hold virtual analyst and investor eventNASDAQ:ARWRArrowhead Pharmaceuticals Inc
14/10/202208:15TipRanksArrowhead Pharmaceuticals (ARWR) Receives a Buy from B.Riley FinancialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/09/202218:33Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ARWR

Seu Histórico Recente

BINA
ILVBTC
Illuvium
NASDAQ
HURN
Huron Consulting
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados